U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1993
136
Name Type Language
ABCIXIMAB
INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
ABCIXIMAB [MI]
Common Name English
Abciximab [WHO-DD]
Common Name English
ABCIXIMAB (GENETICAL RECOMBINATION) [JAN]
Common Name English
C7E3
Code English
ABCIXIMAB [JAN]
Common Name English
abciximab [INN]
Common Name English
ABCIXIMAB [MART.]
Common Name English
MABFRAG CHIMERIC (IGG1) ANTI P08514 (ITA2B_HUMAN) (IBD657)
Common Name English
ABCIXIMAB (GENETICAL RECOMBINATION)
JAN  
Common Name English
ABCIXIMAB [PURPLE BOOK CDER]
Common Name English
ABCIXIMAB [VANDF]
Common Name English
ABCIXIMAB [USAN]
Common Name English
REOPRO
Brand Name English
Immunoglobulin G1, anti-(human integrin αIIbβ3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhCγ1 γ1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ κ-chain
Common Name English
Classification Tree Code System Code
WHO-ATC B01AC13
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
WHO-VATC QB01AC13
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
Code System Code Type Description
LACTMED
Abciximab
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
MESH
C085843
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201584
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
DRUG CENTRAL
4950
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
USAN
FF-7
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
IUPHAR
6584
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
EVMPD
SUB00233MIG
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
FDA UNII
X85G7936GV
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
WIKIPEDIA
ABCIXIMAB
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
NCI_THESAURUS
C76128
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
SMS_ID
100000078823
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
RXCUI
83929
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY RxNorm
INN
7200
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
MERCK INDEX
m1275
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY Merck Index
HSDB
8179
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
CAS
143653-53-6
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
DRUG BANK
DB00054
Created by admin on Sat Dec 16 17:50:36 GMT 2023 , Edited by admin on Sat Dec 16 17:50:36 GMT 2023
PRIMARY
ACTIVE MOIETY
ABCIXIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966